ImmunoPrecise Antibodies Ltd. Form 6-K Filing Insights - December 2024

The key information extracted from the provided section of the financial report, which is a Form 6-K filed by ImmunoPrecise Antibodies Ltd., is as follows:

1. Company Name: ImmunoPrecise Antibodies Ltd.
2. Filing Type: Form 6-K (Report of Foreign Private Issuer)
3. Filing Date: December 23, 2024
4. Commission File Number: 001-39530
5. Address of Principal Executive Office:

• 3204 - 4464 Markham Street
• Victoria, British Columbia, V8Z 7X8, Canada

6. Report Purpose: The filing is made under the Securities Exchange Act of 1934, indicating compliance with reporting requirements for foreign private issuers.
7. Indication of Annual Reports: The report checks 'Form 20-F' indicating that the registrant will file annual reports under this form, while 'Form 40-F' is not checked.
8. Signatory Information:

• Name: Kristin Taylor
• Title: Chief Financial Officer
• Signature: Signed as /s/ Kristin Taylor

These points summarize the essential details and compliance aspects of the filing, which are relevant for stakeholders analyzing the company's regulatory submissions and corporate governance.